Cargando…
Higher Desolvation Energy Reduces Molecular Recognition in Multi-Drug Resistant HIV-1 Protease
Designing HIV-1 protease inhibitors that overcome drug-resistance is still a challenging task. In this study, four clinical isolates of multi-drug resistant HIV-1 proteases that exhibit resistance to all the US FDA-approved HIV-1 protease inhibitors and also reduce the substrate recognition ability...
Autores principales: | Wang, Yong, Dewdney, Tamaria G., Liu, Zhigang, Reiter, Samuel J., Brunzelle, Joseph S., Kovari, Iulia A., Kovari, Ladislau C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011036/ https://www.ncbi.nlm.nih.gov/pubmed/24832048 http://dx.doi.org/10.3390/biology1010081 |
Ejemplares similares
-
The L33F darunavir resistance mutation acts as a molecular anchor reducing the flexibility of the HIV-1 protease 30s and 80s loops
por: Kuiper, Benjamin D., et al.
Publicado: (2015) -
The role of mutations at codons 32, 47, 54, and 90 in HIV-1 protease flap dynamics
por: Chordia, Poorvi, et al.
Publicado: (2014) -
Topochemical control in desolvation of coordination polymers
por: Lusi, Matteo
Publicado: (2015) -
Desolvation
Processes in Channel Solvates of Niclosamide
por: Mann, Jen E., et al.
Publicado: (2023) -
Unveiling the self-association and desolvation in crystal nucleation
por: Li, Danning, et al.
Publicado: (2021)